If 'insiders' in interest-rate sensitive industries are buying, should you?

Genetically modified crops scare uninformed consumers. But not investors. Here's why

Dry bulk shipping isn't exactly the most exciting industry sector to research. Even among sea-borne freight, oil-tanker companies overshadow dry bulk shipping companies. (The price of oil will do that.) But the dry bulkers who carry cargo like...

The proverbial lump of coal is what naughty boys and girls get in their Christmas stockings. But investors who have placed coal stocks in their portfolios over the last year or two have found a gift that keeps on giving. Coal stocks soared by 125...

It's among the thorniest of issues in the investment world: At what point does an underperforming style of investment turn appealing? The style of the moment on this account most certainly is large-cap growth. It has been, bar none, the worst...

Benjamin Franklin once said, Beer is proof that God loves us and wants us to be happy. My how tastes change. Today, Ben might substitute Absolut Raspberri or shiraz for beer. Booze and wine have replaced ordinary suds as the king of cool. Sure...

After announcing General Electric's company-wide push into so-called green technologies in May, Jeffrey Immelt, the company's CEO, stressed that the move is not part of some save-the-planet idealism. Rather, he said, GE's initiative is driven by...

When Morgan Stanley and Dean Witter got married back in 1997, the idea was to create a Wall Street powerhouse: a white shoe investment bank (Morgan Stanley) with a nationwide, albeit work-a-day, distribution network (Dean Witter). That, at least...

A recent New York magazine article declared 2005 a golden age for video games, and anyone who has played Resident Evil 4, Madden NFL 2005 or Grand Theft Auto: San Andreas can agree. What remains to be seen is whether this golden age extends to the...

Wall Street worshiped large pharmaceutical companies for much of the past two decades, and for good reason: The big pharmas had it all rock-solid balance sheets, strong earnings and a seemingly endless pipeline of novel drugs. More recently, the...